---

Top Deal Highlights for Nov 2015:

1. Sun Pharma in talks to buy a portion of Swiss drugmaker Novartis' portfolio of old branded products in Japan in a deal estimated at $300 million
2. Indian drug firms vie for $500-800 million portfolio of world’s largest generic player, Teva
3. Dr Reddy's completes USD 17.5 million purchase of IP rights for Fondaparinux from its Australian partner, Alchemia
4. Piramal Healthcare invests £2 million in Scotland to manufacture Antibody Drug Conjugates for global markets
5. India based Trivitron acquires exclusive distribution rights for Japan based Sakura's histopathology products in India
6. Sun Pharma successfully completes acquisition of InSite Vision, US

Aagami Updates:

1. BIO Europe 2015, Munich, Germany - Aagami completed 35+ one to one partnering meetings. Many of them proved to be fruitful.
2. Aagami CEO to visit India to represent a Texas based client's IP protected technology to address poorly soluble and heat sensitive drugs.